Junfen Ma
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Angiogenesis and VEGF in Cancer 3
- Circular RNAs in diseases 2
- Cancer-related gene regulation 2
- Epigenetics and DNA Methylation 2
- Histone Deacetylase Inhibitors Research 2
- Oncology 6
- Inflammatory Biomarkers in Disease Prognosis 2
- Co-authors
- Liang Ming (9 shared papers)Zhiyun Jiang (7 shared papers)Liang Ming (6 shared papers)Quanbo Zhou (1 shared paper)Ting Sun (1 shared paper)Jiang Li (1 shared paper)Jinbo Liu (1 shared paper)Guixian Wang (1 shared paper)
- Journals
- Medicine (2 papers)Frontiers in Pharmacology (1 paper)Anti-Cancer Agents in Medicinal Chemistry (1 paper)Molecular Cancer (1 paper)Frontiers in Genetics (1 paper)
- Partner nations
- China
In The Last Decade
Junfen Ma
25 papers receiving 1.1k citations
Junfen Ma's Hit Papers
Peers
Comparison fields: 5 of 83
- Cancer Research 439
- Internal Medicine 72
- Molecular Biology 662
- Oncology 149
- Immunology 85
Countries citing papers authored by Junfen Ma
This map shows the geographic impact of Junfen Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfen Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfen Ma more than expected).
Fields of papers citing papers by Junfen Ma
This network shows the impact of papers produced by Junfen Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfen Ma. The network helps show where Junfen Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Junfen Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Exosomal circRNAs: biogenesis, effect and application in human diseases Hit paper breakdown → | 2019 | 517 |
| 2 | 2018 | 133 | |
| 3 | 2015 | 44 | |
| 4 | 2018 | 43 | |
| 5 | 2018 | 38 | |
| 6 | 2019 | 34 | |
| 7 | 2017 | 30 | |
| 8 | 2016 | 26 | |
| 9 | 2019 | 24 | |
| 10 | 2018 | 23 | |
| 11 | 2010 | 22 | |
| 12 | 2017 | 22 | |
| 13 | 2018 | 20 | |
| 14 | 2012 | 19 | |
| 15 | 2019 | 17 | |
| 16 | 2016 | 13 | |
| 17 | 2017 | 13 | |
| 18 | 2020 | 12 | |
| 19 | 2016 | 11 | |
| 20 | 2018 | 9 |
About Junfen Ma
Junfen Ma is a scholar working on Molecular Biology, Oncology, Cancer Research, Immunology and Allergy and Surgery, having authored 25 papers that have together received 1.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), Angiogenesis and VEGF in Cancer (3 papers), Cell Adhesion Molecules Research (3 papers), Circular RNAs in diseases (2 papers), Cancer-related gene regulation (2 papers), Epigenetics and DNA Methylation (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and Inflammatory Biomarkers in Disease Prognosis (2 papers). The work is most often cited by research in Cancer Research (439 citations), Internal Medicine (72 citations), Molecular Biology (662 citations), Oncology (149 citations) and Immunology (85 citations). Junfen Ma has collaborated with scholars based in China. Frequent co-authors include Liang Ming, Zhiyun Jiang, Liang Ming, Quanbo Zhou, Ting Sun, Jiang Li, Jinbo Liu, Guixian Wang, Yangxia Wang and Zhenqiang Sun. Their work appears in journals such as Medicine, Frontiers in Pharmacology, Anti-Cancer Agents in Medicinal Chemistry, Molecular Cancer and Frontiers in Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.